VeriSign (VRSN) 10-Q 23 Apr 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	3 Months Ended
	Mar. 31, 2020	Apr. 17, 2020
Document And Entity Information [Abstract]
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	VRSN
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3221585
Entity Address, Postal Zip Code	20190
Document Transition Report	false
Document Quarterly Report	true
Entity Registrant Name	VERISIGN INC/CA
Entity Central Index Key	0001014473
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Entity File Number	000-23593
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		115,539,476
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Address, Address Line One	12061 Bluemont Way,
Entity Address, City or Town	Reston,
Entity Address, State or Province	VA
City Area Code	703
Local Phone Number	948-3200
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 498,693	$ 508,196
Marketable securities	639,939	709,863
Other Assets, Current	46,863	60,530
Total current assets	1,185,495	1,278,589
Property and equipment, net	247,764	250,283
Goodwill	52,527	52,527
Deferred Income Tax Assets, Net	84,388	87,798
Deposits to acquire Intangible Assets	145,000	145,000
Other long-term assets	38,687	39,812
Total long-term assets	568,366	575,420
Total assets	1,753,861	1,854,009
Current liabilities:
Accounts payable and accrued liabilities	180,015	209,988
Deferred revenues	775,657	755,178
Total current liabilities	955,672	965,166
Long-term deferred revenues	281,030	278,702
Senior Notes	1,788,194	1,787,565
Other long-term liabilities	138,079	312,676
Total long-term liabilities	2,207,303	2,378,943
Total liabilities	3,162,975	3,344,109
Commitments and contingencies
Stockholders' deficit:
Preferred stock-par value $.001 per share	0	0
Common Stocks, Including Additional Paid in Capital	14,734,618	14,990,011
Accumulated deficit	(16,143,374)	(16,477,490)
Accumulated other comprehensive loss	(358)	(2,621)
Total stockholders' deficit	(1,409,114)	(1,490,100)
Total liabilities and stockholders' deficit	$ 1,753,861	$ 1,854,009

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized shares	5,000	5,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized shares	1,000,000	1,000,000
Common Stock, Shares, Issued	353,577	353,157
Common stock, outstanding shares	115,701	116,715

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues	$ 312,524	$ 306,408
Costs and expenses:
Cost of revenues	45,573	45,504
Sales and marketing	6,604	10,519
Research and development	17,358	16,132
General and administrative	36,725	34,001
Total costs and expenses	106,260	106,156
Operating income	206,264	200,252
Interest expense	(22,535)	(22,631)
Non-operating income (loss), net	7,084	12,203
Income before income taxes	190,813	189,824
Income tax expense	143,303	(27,297)
Net Income	334,116	162,527
Other comprehensive income (loss)	2,263	49
Comprehensive Income	$ 336,379	$ 162,576
Basic income (loss) per share
Net Income	$ 2.87	$ 1.36
Diluted income (loss) per share
Net Income	$ 2.86	$ 1.35
Shares used to compute net income per share
Basic	116,375	119,757
Diluted	116,730	120,317

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit Statement - USD ($) $ in Thousands	Total	Common Stock Including Additional Paid in Capital [Member]	Accumulated Deficit [Member]	AOCI Attributable to Parent [Member]
Stockholders' Deficit	$ (1,385,474)	$ 15,707,126	$ (17,089,789)	$ (2,811)
Stock-based compensation expense		12,818
Stock Issued During Period, Value, Employee Stock Purchase Plan		8,253
Stock Repurchased During Period, Value		(204,302)
Net Income	162,527		162,527
Other Comprehensive Income (Loss), Net of Tax	49			49
Stockholders' Deficit	(1,406,129)	15,523,895	(16,927,262)	(2,762)
Stockholders' Deficit	(1,490,100)	14,990,011	(16,477,490)	(2,621)
Stock-based compensation expense		11,934
Stock Issued During Period, Value, Employee Stock Purchase Plan		8,296
Stock Repurchased During Period, Value		(275,623)
Net Income	334,116		334,116
Other Comprehensive Income (Loss), Net of Tax	2,263			2,263
Stockholders' Deficit	$ (1,409,114)	$ 14,734,618	$ (16,143,374)	$ (358)

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 334,116	$ 162,527
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property and equipment	11,232	11,593
Stock-based compensation	11,441	12,462
Accretion (Amortization) of Discounts and Premiums, Investments	(3,003)	(3,854)
Other Noncash Income (Expense)	(1,692)	147
Changes in operating assets and liabilities
Other assets	28	(226)
Accounts payable and accrued liabilities	(27,409)	(31,609)
Deferred revenues	22,807	29,219
Deferred Income Taxes	(170,844)	7,365
Net cash provided by operating activities	180,060	187,330
Net Cash Provided by (Used in) Investing Activities [Abstract]
Proceeds from maturities and sales of marketable securities	805,748	939,561
Purchases of marketable securities	(730,507)	(496,779)
Payments for (Proceeds from) Businesses and Interest in Affiliates	14,856	(2,958)
Purchases of property and equipment	(11,013)	(9,133)
Net cash used in investing activities	79,084	430,691
Cash flows from financing activities:
Proceeds from employee stock purchase plans	8,296	8,253
Repurchases of common stock	(275,623)	(204,302)
Net cash used in financing activities	(267,327)	(196,049)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(1,316)	255
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(9,499)	422,227
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period	517,601	366,753
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period	508,102	788,980
Supplemental cash flow disclosures:
Cash paid for interest	13,151	13,063
Cash paid for income taxes, net of refunds received	$ 15,914	$ 14,185

Basis Of Presentation

Basis Of Presentation	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis Of Presentation	Basis of Presentation Interim Financial Statements The accompanying unaudited Condensed Consolidated Financial Statements have been prepared by VeriSign, Inc. (“Verisign” or the “Company”) in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and notes normally provided in audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included. The results of operations for any interim period are not necessarily indicative of, nor comparable to, the results of operations for any other interim period or for a full fiscal year. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and related notes contained in Verisign’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “ 2019 Form 10-K”) filed with the SEC on February 14, 2020. Reclassifications Certain reclassifications have been made to prior period amounts to conform to current period presentation. Such reclassifications have no effect on net income as previously reported.

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2020
Financial Instruments, Owned, at Fair Value [Abstract]
Financial Instruments	Cash, Cash Equivalents, and Marketable Securities The following table summarizes the Company’s cash, cash equivalents, and marketable securities and the fair value categorization of the financial instruments measured at fair value on a recurring basis: March 31, December 31, 2020 2019 (In thousands) Cash $ 24,850 $ 33,238 Time deposits 5,044 3,924 Money market funds (Level 1) 128,213 149,624 Debt securities issued by the U.S. Treasury (Level 1) 989,934 1,040,678 Total $ 1,148,041 $ 1,227,464 Cash and cash equivalents $ 498,693 $ 508,196 Restricted cash (included in Other long-term assets) 9,409 9,405 Total Cash, cash equivalents, and restricted cash 508,102 517,601 Marketable securities 639,939 709,863 Total $ 1,148,041 $ 1,227,464 The fair value of the debt securities held as of March 31, 2020 was $989.9 million , including $2.4 million of gross and net unrealized gains. All of the debt securities held as of March 31, 2020 are scheduled to mature in less than one year. Fair Value Measurements The fair value of the Company’s investments in money market funds approximates their face value. Such instruments are included in Cash and cash equivalents. The fair value of the debt securities consisting of U.S. Treasury bills is based on their quoted market prices. Debt securities purchased with original maturities in excess of three months are included in Marketable securities. The fair value of all of these financial instruments are classified as Level 1 in the fair value hierarchy. The Company’s other financial instruments include cash, accounts receivable, restricted cash, and accounts payable. As of March 31, 2020 , the carrying value of these financial instruments approximated their fair value. The fair values of the senior notes due 2023, 2025, and 2027 were $751.6 million , $511.6 million , and $575.0 million , respectively, as of March 31, 2020

Other Balance Sheet Items

Other Balance Sheet Items	3 Months Ended
	Mar. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Other Balance Sheet Items	Selected Balance Sheet Items Other Current Assets Other current assets consist of the following: March 31, December 31, 2020 2019 (In thousands) Prepaid registry fees $ 22,286 $ 21,717 Prepaid expenses 16,611 19,818 Accounts receivable, net 5,047 1,524 Contingent consideration receivable — 14,721 Other 2,919 2,750 Total other current assets $ 46,863 $ 60,530 During the three months ended March 31, 2020 the Company received $ 15.2 million contingent consideration related to its divested security services business. The excess of the proceeds received over the balance of the receivable was recognized as a gain and included in Non-operating income, net. Other Long-Term Assets Other long-term assets consist of the following: March 31, December 31, 2020 2019 (In thousands) Restricted cash $ 9,409 $ 9,405 Operating lease right-of-use asset 8,645 9,133 Long-term prepaid registry fees 7,851 7,753 Other tax receivable 6,927 6,927 Other 5,855 6,594 Total other long-term assets $ 38,687 $ 39,812 The current and long-term prepaid registry fees in the tables above relate to the fees the Company pays to ICANN for each annual increment of . com domain name registrations and renewals which are deferred and amortized over the domain name registration term. The amount of prepaid registry fees as of March 31, 2020 reflects amortization of $8.9 million during the three months ended March 31, 2020 which was recorded in Cost of Revenues. Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of the following: March 31, December 31, 2020 2019 (In thousands) Accounts payable and accrued expenses $ 10,434 $ 17,177 Customer deposits, net 43,376 52,804 Taxes payable and other tax liabilities 44,847 33,435 Interest payable 33,021 24,318 Accrued employee compensation 26,022 49,869 Accrued registry fees 12,391 11,529 Customer incentives payable 5,503 13,547 Other accrued liabilities 4,421 7,309 Total accounts payable and accrued liabilities $ 180,015 $ 209,988 Customer deposits primarily relate to advance payments to cover domain name registration activity by registrars. The balance of customer deposits can fluctuate significantly due to the timing of payments from large customers. Taxes payable and other tax liabilities reflect the income tax provision and payments made during the period. Interest payable varies at each period-end based on the payment due dates for each Senior Note issuance. Accrued employee compensation primarily consists of liabilities for employee leave, salaries, payroll taxes, employee contributions to the employee stock purchase plan, and incentive compensation. Accrued employee incentive compensation as of December 31, 2019 , was paid during the three months ended March 31, 2020 . Customer incentives payable includes amounts related to rebates and marketing programs payable to registrars. These amounts may vary from period to period due to the timing of payments. Long-term tax and other liabilities March 31, December 31, 2020 2019 (In thousands) Long-term tax liabilities $ 133,858 $ 308,112 Long-term operating lease liability 4,221 4,564 Long-term tax and other liabilities $ 138,079 $ 312,676 During the three months ended March 31, 2020 , the Company remeasured its previously unrecognized income tax benefits relating to the worthless stock deduction taken in 2013. The remeasurement resulted in the recognition of a $ 167.8 million

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Stockholders' (Deficit) Equity	Stockholders’ Deficit Effective February 6, 2020, the Company’s Board of Directors authorized the repurchase of its common stock in the amount of $ 743.0 million , in addition to the $ 257.0 million that remained available for repurchases under the share repurchase program, for a total repurchase authorization of up to $1.0 billion under the program. The program has no expiration date. Purchases made under the program could be effected through open market transactions, block purchases, accelerated share repurchase agreements or other negotiated transactions. During the three months ended March 31, 2020 , the Company repurchased 1.3 million shares of its common stock at an average stock price of $190.14 . The aggregate cost of the repurchases in the three months ended March 31, 2020 was $245.0 million . As of March 31, 2020 , there was approximately $825.6 million remaining available for future share repurchases under the share repurchase program. During the three months ended March 31, 2020 , the Company placed 0.1 million shares, at an average stock price of $209.40 , and for an aggregate cost of $30.7 million , into treasury stock for purposes related to tax withholding upon vesting of Restricted Stock Units (“RSUs”). Since inception, the Company has repurchased 237.9 million shares of its common stock for an aggregate cost of $10.48 billion , which is presented as a reduction of Additional paid-in capital.

Calculation Of Net Income Per S

Calculation Of Net Income Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Calculation Of Net Income Per Share Attributable To Verisign Stockholders	Calculation of Earnings per Share The following table presents the computation of weighted-average shares used in the calculation of basic and diluted earnings per share: Three Months Ended 2020 2019 (In thousands) Weighted-average shares of common stock outstanding 116,375 119,757 Weighted-average potential shares of common stock outstanding: Unvested RSUs and ESPP 355 560 Shares used to compute diluted earnings per share 116,730 120,317 The calculation of diluted weighted average shares outstanding excludes performance-based RSUs granted by the Company for which the relevant performance criteria have not been achieved. The number of potential shares excluded from the calculation was not significant in any period presented.

Revenue (Notes)

Revenue (Notes)	3 Months Ended
	Mar. 31, 2020
Revenue Recognition [Abstract]
Revenue from Contract with Customer [Table Text Block]	Revenues The Company generates revenues in the U.S.; Europe, the Middle East and Africa (“EMEA”); China; and certain other countries, including Canada, Australia, and Japan. The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers: Three Months Ended 2020 2019 (In thousands) U.S. $ 197,503 $ 192,155 EMEA 52,105 52,146 China 30,187 28,242 Other 32,729 33,865 Total revenues $ 312,524 $ 306,408 Revenues in the table above are attributed to the country of domicile and the respective regions in which registrars are located; however, this may differ from the regions where the registrars operate or where registrants are located. Revenues for each region may be impacted by registrars reincorporating, relocating, or from acquisitions or changes in affiliations of resellers. Revenues for each region may also be impacted by registrars domiciled in one region, registering domain names in another region. Deferred Revenues As payment for domain name registrations and renewals are due in advance of our performance, we record these amounts as deferred revenues. The increase in the deferred revenues balance for the three months ended March 31, 2020 was primarily driven by amounts billed in the first quarter of 2020 for domain name registrations and renewals to be recognized as revenues in future periods, offset by refunds for domain name renewals deleted during the 45-day grace period, and $ 278.5 million of revenues recognized that were included in the deferred revenues balance at the beginning of the period. The balance of deferred revenues as of March 31, 2020 represents our aggregate remaining performance obligations. Amounts included in current deferred revenues are all expected to be recognized in revenues within 12 months, except for a portion of deferred revenues that relates to domain name renewals that are deleted in the 45-day grace period following the transaction. The long-term deferred revenues amounts will be recognized in revenues over several years and in some cases up to 10 years.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation	Stock-based Compensation Stock-based compensation is classified in the Condensed Consolidated Statements of Comprehensive Income in the same expense line items as cash compensation. The following table presents the classification of stock-based compensation: Three Months Ended 2020 2019 (In thousands) Cost of revenues $ 1,648 $ 1,598 Sales and marketing 885 983 Research and development 1,676 1,589 General and administrative 7,232 8,292 Total stock-based compensation expense $ 11,441 $ 12,462 The following table presents the nature of the Company’s total stock-based compensation: Three Months Ended 2020 2019 (In thousands) RSUs $ 9,087 $ 8,609 Performance-based RSUs 1,717 3,038 ESPP 1,130 1,171 Capitalization (included in Property and equipment, net) (493 ) (356 ) Total stock-based compensation expense $ 11,441 $ 12,462

Non-operating (loss) income

Non-operating (loss) income	3 Months Ended
	Mar. 31, 2020
Non-operating (loss) income, net [Abstract]
Other Income and Other Expense Disclosure [Text Block]	Non-operating Income, Net The following table presents the components of Non-operating income, net: Three Months Ended 2020 2019 (In thousands) Interest income $ 4,421 $ 7,360 Transition services income 2,100 4,050 Other, net 563 793 Total non-operating income, net $ 7,084 $ 12,203 The transition services income related to services provided to transition the divested security services business. The transition services agreement ended in February 2020.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table presents Income tax (benefit) expense and the effective tax rate: Three Months Ended 2020 2019 (Dollars in thousands) Income tax (benefit) expense $ (143,303 ) $ 27,297 Effective tax rate (75 )% 14 % During the three months ended March 31, 2020, the Company remeasured its previously unrecognized income tax benefits relating to the worthless stock deduction taken in 2013. The remeasurement, which resulted in the recognition of a $167.8 million benefit in the quarter, was based on Internal Revenue Service (“IRS”) written confirmation indicating no examination adjustment would be proposed. Notwithstanding this written confirmation, the Company’s U.S. federal income tax returns remain under examination by the IRS for 2010 through 2014. The timing of completion and ultimate outcome of the audits remains uncertain and it is reasonably possible that during the next 12 months, the Company’s unrecognized tax benefits may change further as a result of IRS audits. The effective tax rate for the three months ended March 31, 2020 was lower than the statutory federal rate of 21% primarily due to the remeasurement of unrecognized tax benefits mentioned above, foreign income taxed at lower rates, and $11.8 million of excess tax benefits related to stock-based compensation, partially offset by state income taxes. The effective tax rate for the three months ended March 31, 2019 was lower than the statutory federal rate of 21% primarily due to tax benefits from foreign income taxed at lower rates and $11.0 million of excess tax benefits related to stock-based compensation, partially offset by state income taxes.

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Financial Instruments, Owned, at Fair Value [Abstract]
Cash, Cash Equivalents, And Marketable Securities	The following table summarizes the Company’s cash, cash equivalents, and marketable securities and the fair value categorization of the financial instruments measured at fair value on a recurring basis: March 31, December 31, 2020 2019 (In thousands) Cash $ 24,850 $ 33,238 Time deposits 5,044 3,924 Money market funds (Level 1) 128,213 149,624 Debt securities issued by the U.S. Treasury (Level 1) 989,934 1,040,678 Total $ 1,148,041 $ 1,227,464 Cash and cash equivalents $ 498,693 $ 508,196 Restricted cash (included in Other long-term assets) 9,409 9,405 Total Cash, cash equivalents, and restricted cash 508,102 517,601 Marketable securities 639,939 709,863 Total $ 1,148,041 $ 1,227,464

Other Balance Sheet Items (Tabl

Other Balance Sheet Items (Tables)	3 Months Ended
	Mar. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Other Current Assets	Other current assets consist of the following: March 31, December 31, 2020 2019 (In thousands) Prepaid registry fees $ 22,286 $ 21,717 Prepaid expenses 16,611 19,818 Accounts receivable, net 5,047 1,524 Contingent consideration receivable — 14,721 Other 2,919 2,750 Total other current assets $ 46,863 $ 60,530
Schedule of Other Assets, Noncurrent [Table Text Block]	Other long-term assets consist of the following: March 31, December 31, 2020 2019 (In thousands) Restricted cash $ 9,409 $ 9,405 Operating lease right-of-use asset 8,645 9,133 Long-term prepaid registry fees 7,851 7,753 Other tax receivable 6,927 6,927 Other 5,855 6,594 Total other long-term assets $ 38,687 $ 39,812
Components Of Accounts Payable And Accrued Liabilities	Accounts payable and accrued liabilities consist of the following: March 31, December 31, 2020 2019 (In thousands) Accounts payable and accrued expenses $ 10,434 $ 17,177 Customer deposits, net 43,376 52,804 Taxes payable and other tax liabilities 44,847 33,435 Interest payable 33,021 24,318 Accrued employee compensation 26,022 49,869 Accrued registry fees 12,391 11,529 Customer incentives payable 5,503 13,547 Other accrued liabilities 4,421 7,309 Total accounts payable and accrued liabilities $ 180,015 $ 209,988
Other Noncurrent Liabilities [Table Text Block]	Long-term tax and other liabilities March 31, December 31, 2020 2019 (In thousands) Long-term tax liabilities $ 133,858 $ 308,112 Long-term operating lease liability 4,221 4,564 Long-term tax and other liabilities $ 138,079 $ 312,676

Calculation Of Net Income Per_2

Calculation Of Net Income Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares [Table Text Block]	The following table presents the computation of weighted-average shares used in the calculation of basic and diluted earnings per share: Three Months Ended 2020 2019 (In thousands) Weighted-average shares of common stock outstanding 116,375 119,757 Weighted-average potential shares of common stock outstanding: Unvested RSUs and ESPP 355 560 Shares used to compute diluted earnings per share 116,730 120,317

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue Recognition [Abstract]
Disaggregation of Revenue [Table Text Block]	The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers: Three Months Ended 2020 2019 (In thousands) U.S. $ 197,503 $ 192,155 EMEA 52,105 52,146 China 30,187 28,242 Other 32,729 33,865 Total revenues $ 312,524 $ 306,408

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Classification Of Stock-Based Compensation	The following table presents the classification of stock-based compensation: Three Months Ended 2020 2019 (In thousands) Cost of revenues $ 1,648 $ 1,598 Sales and marketing 885 983 Research and development 1,676 1,589 General and administrative 7,232 8,292 Total stock-based compensation expense $ 11,441 $ 12,462
Nature Of Total Stock-Based Compensation	The following table presents the nature of the Company’s total stock-based compensation: Three Months Ended 2020 2019 (In thousands) RSUs $ 9,087 $ 8,609 Performance-based RSUs 1,717 3,038 ESPP 1,130 1,171 Capitalization (included in Property and equipment, net) (493 ) (356 ) Total stock-based compensation expense $ 11,441 $ 12,462

Non-operating (loss) income (Ta

Non-operating (loss) income (Tables)	3 Months Ended
	Mar. 31, 2020
Non-operating (loss) income, net [Abstract]
Schedule of Other Nonoperating Income (Expense) [Table Text Block]	The following table presents the components of Non-operating income, net: Three Months Ended 2020 2019 (In thousands) Interest income $ 4,421 $ 7,360 Transition services income 2,100 4,050 Other, net 563 793 Total non-operating income, net $ 7,084 $ 12,203

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Tax Expense From Continuing Operations And The Effective Tax Rate	The following table presents Income tax (benefit) expense and the effective tax rate: Three Months Ended 2020 2019 (Dollars in thousands) Income tax (benefit) expense $ (143,303 ) $ 27,297 Effective tax rate (75 )% 14 %

Financial Instruments (Details)

Financial Instruments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Mar. 31, 2020
Cash	$ 24,850	$ 33,238
Time deposits	5,044	3,924
Money Market Funds (level 1)	128,213	149,624
Financial Instruments, Owned, US Government and Agency Obligations, at Fair Value	989,934	1,040,678
Total	1,148,041	1,227,464
Included in Cash and cash equivalents	498,693	508,196
Restricted Cash Equivalents, Noncurrent	9,409	9,405
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	508,102	517,601	$ 788,980	$ 366,753
Included in Marketable securities	$ 639,939	$ 709,863

Financial Instruments Financial

Financial Instruments Financial Instruments narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Document Period End Date	Mar. 31, 2020
Financial Instruments, Owned, US Government and Agency Obligations, at Fair Value	$ 989,934	$ 1,040,678
Debt securities gross unrealized gains	2,400
Debt instrument fair value senior notes 2023	751,600
Debt instrument fair value senior notes 2025	511,600
Debt instrument fair value senior notes 2027	$ 575,000

Other Balance Sheet Items (Othe

Other Balance Sheet Items (Other Current Assets) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Contingent consideration proceeds	$ 15,200
Prepaid registry fees, current	22,286	$ 21,717
Estimated contingent consideration receivable	0	14,721
Prepaid expenses	16,611	19,818
Accounts Receivable, Net	5,047	1,524
Other Assets, Miscellaneous, Current	2,919	2,750
Other Assets, Current	$ 46,863	$ 60,530

Other Balance Sheet Items Other

Other Balance Sheet Items Other Balance Sheet Items (Other long-term assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Restricted Cash	$ 9,409	$ 9,405
Operating Lease, Right-of-Use Asset	8,645	9,133
Prepaid registry fees, noncurent	7,851	7,753
Income Taxes Receivable, Noncurrent	6,927	6,927
Other Assets, Miscellaneous, Noncurrent	5,855	6,594
Other Assets, Noncurrent	$ 38,687	$ 39,812

Other Balance Sheet Items (Comp

Other Balance Sheet Items (Components Of Accounts Payable And Accrued Liabilities) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Accounts payable	$ 10,434	$ 17,177
Accrued employee compensation	26,022	49,869
Taxes Payable	33,021	24,318
Interest Payable	44,847	33,435
Deposits, net	43,376	52,804
accrued fees	5,503	13,547
Due to buyer	12,391	11,529
Other accrued liabilities	4,421	7,309
Total accounts payable and accrued liabilities	$ 180,015	$ 209,988

Other Balance Sheet Items Oth_2

Other Balance Sheet Items Other Balance Sheet Items (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Operating Lease, Right-of-Use Asset	$ 8,645	$ 9,133
Amortization of Other Deferred Charges	$ 8,900

Other Balance Sheet Items Oth_3

Other Balance Sheet Items Other Balance Sheet Items (Long-term tax and other liabilities) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Long-term tax and other liabilities Disclosure [Abstract]
Unrecognized Tax Benefits	$ 133,858	$ 308,112
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	167,800
Operating Lease, Liability, Noncurrent	4,221	4,564
Other long-term liabilities	$ 138,079	$ 312,676

Stockholders' Deficit (Narrativ

Stockholders' Deficit (Narrative) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Feb. 06, 2020
Treasury Stock Repurchase Programs [Line Items]
Additional share repurchase amount authorized	$ 743
Remaining common stock available for repurchase	$ 825.6	$ 257
Common stock, held in treasury	237.9
Common stock repurchased	$ 10,480
Share Buyback Program [Member]
Treasury Stock Repurchase Programs [Line Items]
Common stock authorized to repurchase		$ 1,000
Common stock repurchase, share	1.3
Average stock price	$ 190.14
Aggregate cost of share	$ 245
Restricted Stock Units [Member]
Treasury Stock Repurchase Programs [Line Items]
Common stock repurchase, share	0.1
Average stock price	$ 209.40
Aggregate cost of share	$ 30.7

Calculation Of Net Income Per_3

Calculation Of Net Income Per Share (Weighted-Average Shares Used In Calculation Of Basic And Diluted EPS) (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Weighted-average number of common shares outstanding	116,375	119,757
Unvested RSUs and ESPP	355	560
Shares used to compute diluted net income per share	116,730	120,317

Revenue (Details)

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Revenues	$ 312,524	$ 306,408
US [Member]
Disaggregation of Revenue [Line Items]
Revenues	197,503	192,155
EMEA [Member]
Disaggregation of Revenue [Line Items]
Revenues	52,105	52,146
China [Member]
Disaggregation of Revenue [Line Items]
Revenues	30,187	28,242
Other [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 32,729	$ 33,865

Revenue Revenue (Narrative deta

Revenue Revenue (Narrative detail) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Revenue Recognition and Deferred Revenue [Abstract]
Deferred Revenue, Revenue Recognized	$ 278.5

Stock-Based Compensation (Class

Stock-Based Compensation (Classification Of Stock-Based Compensation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$ 11,441	$ 12,462
Cost Of Revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	1,648	1,598
Sales And Marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	885	983
Research And Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	1,676	1,589
General And Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$ 7,232	$ 8,292

Stock-Based Compensation (Natur

Stock-Based Compensation (Nature Of Total Stock-Based Compensation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Amount Capitalized	$ (493)	$ (356)
Stock-based compensation	11,441	12,462
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	9,087	8,609
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	1,717	3,038
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 1,130	$ 1,171

Non-operating (loss) income (De

Non-operating (loss) income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Non-operating (loss) income, net [Abstract]
Interest Income	$ 4,421	$ 7,360
income from transition services	2,100	4,050
Other Nonoperating Income (Expense)	563	793
Nonoperating (loss) Income	$ 7,084	$ 12,203

Income Taxes (Income Tax Expens

Income Taxes (Income Tax Expense From Continuing Operations And Effective Tax Rate) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Income tax expense from continuing operations	$ (143,303)	$ 27,297
Effective tax rate	(75.00%)	14.00%

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities	$ 167.8
Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount	$ 11.8	$ 11
Statutory federal rate	21.00%	21.00%